FIELD: medicine.
SUBSTANCE: implementing the method of treating is ensured by sampling a mammal in need of reducing circulating galectin-3 levels, and performing a blood plasmapheresis in the above mammal. The plasmapheresis is performed to reduce circulating active gal-3 levels so as to remove at least ten percent of circulating gal-2 in individual's serum by means of the plasmapheresis. Using the invention provides binding and blocking gal-3 activity in the circulation or removing bulks of gal-3 from the circulation.
EFFECT: improving the existing conservative management, suppressing or reducing inflammation and fibrosis caused by the other ones, and enabling intervention into various painful conditions, which are not treated otherwise.
23 cl
